S21-113 CDK19-SELECTIVE INHIBITORS, AND METHODS OF USE THEREOF Technology Reference CZ Biohub ref. no. CZB-207S Stanford ref. no. S21-113 Vinnie Alford Mark Smith Michael Clarke Jitendra Gurjar
S20-084 CDK19- Selective Inhibitors, and Methods of Use thereof Researchers at Stanford University have identified new CDK19-selective inhibitors for the treatment of triple negative breast cancer. Robert Hsieh Mark Smith Michael Clarke Vinnie Alford Andre St. Amant